34
Publications
2.1K
Citations
24
H-Index
1987
Active since
Helle Linnebjerg is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and diabetes.
Top concepts
MedicinePharmacologyDiabetesPharmacotherapyCardiovascular DiseasePhysiologyThrombosisAtherosclerosisGastroenterologyPharmacokinetics
Publications per year
1987–2025
34
34
Effect of renal impairment on the pharmacokinetics of exenatide
Helle Linnebjerg, Prajakti A. Kothare, Soomin Park et al. · British Journal of Clinical Pharmacology · 2007 · 198 citations · Full text
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
Steven E. Nissen, Helle Linnebjerg, Xi Shen et al. · JAMA · 2023 · 172 citations · Full text
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
Stephen J. Nicholls, Steven E. Nissen, Cynthia Griggs Fleming et al. · JAMA · 2023 · 161 citations · Full text
Rows per page
1–5 of 34